Respiratory

Filter

Healthcare professional speaking with older patient in bed during assessment for ALS sleep disturbances and respiratory dysfunction.

Sleep Changes May Flag Respiratory Decline in ALS

June 2026

ALS sleep disturbances may signal respiratory decline before daytime symptoms become clinically apparent, supporting earlier sleep assessment.

Healthcare professional speaking with older patient in bed during assessment for ALS sleep disturbances and respiratory dysfunction.

Sleep Changes May Flag Respiratory Decline in ALS

ALS sleep disturbances may signal respiratory decline before daytime symptoms become clinically apparent, supporting earlier sleep assessment.

Doctor performing a lung exam during assessment for fibrotic interstitial lung disease.

e-Lung Tool Flags Fibrotic ILD Progression

e-Lung CT biomarkers were linked to mortality and future lung function decline in fibrotic interstitial lung diseases.

Blurred hospital corridor representing clinical outcomes after private equity hospital acquisition.

Private Equity Hospitals See More Asthma Revisits

Private equity hospitals saw worse pulmonary outcomes after acquisition, with higher asthma and COPD revisit rates.

Older adult discussing metastatic NSCLC treatment options with an oncology clinician.

Metastatic NSCLC Treatment Lags in Older Adults

Metastatic NSCLC treatment reached fewer than half of older adults, despite major advances in systemic therapy.

Patient with COPD using an inhaler during digital COPD inhaler training.

Digital COPD Training May Reduce Inhaler Errors

Digital COPD inhaler training reduced technique errors and improved assessment of inspiratory capacity in a new study.

Older adult discussing metastatic NSCLC treatment options with an oncology clinician.

Metastatic NSCLC Treatment Remains Low in Older Adults

Metastatic NSCLC treatment remains underused among older adults, despite major therapeutic advances over 15 years.

Clinicians reviewing lung imaging in a discussion about nontuberculous mycobacterial lung disease.

Airway Inflammation Linked to Mycobacterial Lung Disease

Nontuberculous mycobacterial lung disease may be shaped by airway inflammation, disease severity, and infection duration.

ATS 2026: Ralinepag Trial Targets PAH Disease Progression

Ralinepag may offer once daily prostacyclin pathway targeting for PAH patients already receiving background therapy.

Loading posts...

1 2 3 … 36 Next »